The effect of CCL19/CCR7 on the proliferation and migration of cell in prostate cancer

The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer

(2015) Tao Wang et al.   Oncotarget

Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells

(2015) Pamela J. Maxwell et al.   Oncotarget

Antitumor Efficacy of CC Motif Chemokine Ligand 19 in Colorectal Cancer

(2014) Jun Lu et al.   DIGESTIVE DISEASES AND SCIENCES

Prostate cancer research in China

(2013) Shan-Cheng Ren et al.   ASIAN JOURNAL OF ANDROLOGY

IL-18-based combinatorial adjuvants promote the intranodal production of CCL19 by NK cells and dendritic cells of cancer patients

(2013) Jeffrey L. Wong et al.   OncoImmunology

CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma

(2012) Q. Gao et al.   CANCER RESEARCH

The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer

(2012) Fred Saad et al.   Future Oncology

The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis

(2012) Helenisa Helena Oliveira-Neto et al.   TUMOR BIOLOGY

Update on castrate-resistant prostate cancer: 2010

(2010) Kiran Lassi et al.   CURRENT OPINION IN ONCOLOGY

EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease

(2010) Axel Heidenreich et al.   EUROPEAN UROLOGY

Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells

(2009) M Kochetkova et al.   CELL DEATH AND DIFFERENTIATION

Tumour-immune cell interactions modulated by chemokines

(2008) Karin Jöhrer et al.   EXPERT OPINION ON BIOLOGICAL THERAPY